skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [1];  [2]; ;  [1];  [3]
  1. Penn State Hershey Cancer Institute, Penn State University College of Medicine, Hershey, PA 17033 (United States)
  2. Pharmacy College, Fujian University of Traditional Chinese Medicine, Fuzhou (China)
  3. Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201 (United States)

Adult T cell leukemia and lymphoma (ATL) is a highly aggressive form of hematological malignancy and is caused by chronic infection of human T cell leukemia virus type 1 (HTLV-1). The viral genome encodes an oncogenic protein, Tax, which plays a key role in transactivating viral gene transcription and in deregulating cellular oncogenic signaling to promote survival, proliferation and transformation of virally infected T cells. Hence, Tax is a desirable therapeutic target, particularly at early stage of HTLV-1-mediated oncogenesis. We here show that niclosamide, an anti-helminthic molecule, induced apoptosis of HTLV-1-transformed T cells. Niclosamide facilitated degradation of the Tax protein in proteasome. Consistent with niclosamide-mediated Tax degradation, this compound inhibited activities of MAPK/ERK1/2 and IκB kinases. In addition, niclosamide downregulated Stat3 and pro-survival Bcl-2 family members such as Mcl-1 and repressed the viral gene transcription of HTLV-1 through induction of Tax degradation. Since Tax, Stat3 and Mcl-1 are crucial molecules for promoting survival and growth of HTLV-1-transformed T cells, our findings demonstrate a novel mechanism of niclosamide in inducing Tax degradation and downregulating various cellular pro-survival molecules, thereby promoting apoptosis of HTLV-1-associated leukemia cells. - Highlights: • Niclosamide is a promising therapeutic candidate for adult T cell leukemia. • Niclosamide employs a novel mechanism through proteasomal degradation of Tax. • Niclosamide downregulates certain cellular pro-survival molecules.

OSTI ID:
22462184
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 464, Issue 1; Other Information: Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions
Journal Article · Tue Dec 15 00:00:00 EST 2015 · Virology · OSTI ID:22462184

Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro
Journal Article · Thu Feb 01 00:00:00 EST 1990 · Proceedings of the National Academy of Sciences of the United States of America; (USA) · OSTI ID:22462184

Signal transduction and downregulation of C-MET in HGF stimulated low and highly metastatic human osteosarcoma cells
Journal Article · Fri Sep 04 00:00:00 EDT 2015 · Biochemical and Biophysical Research Communications · OSTI ID:22462184